With legalised cannabis, a new multi-billion-dollar industry is beginning to flower. But Britain won’t get a look-in, says Matthew Lynn.
Articles written by Matthew Lynn
When established big companies invest in new technologies, investors shrug. Why is that happening? asks Matthew Lynn.
Sometimes business leaders deserve their fat pay packets, says Matthew Lynn. Countrywide is a case in point.
As emerging economies wobble there are bargains to be had for businesses buying abroad, says Matthew Lynn.
Fidelity has introduced two tracker funds with no fees at all. Other industries will adopt a similar model. But how can you make a profit when the price of your product has fallen to zero?
Britain’s big drug companies lead the world, but they are stagnating, says Matthew Lynn. Time for a shake-up.
New rules to give workers a say sound sensible, says Matthew Lynn. But public companies are already overburdened.
Fewer analysts and corporate raiders means many firms are sitting on gold mines no one knows about, says Matthew Lynn.
Policymakers are searching for solutions to problems that might well not exist, says Matthew Lynn.
Co-ops have been hailed as a model for a fairer capitalism. But they remain unpopular for a reason, says Matthew Lynn.